Literature DB >> 12402252

Long-term amygdalohippocampal stimulation for refractory temporal lobe epilepsy.

Kristl Vonck1, Paul Boon, Erik Achten, Jacques De Reuck, Jacques Caemaert.   

Abstract

Short-term deep brain stimulation (DBS) recently has been shown to be efficacious in refractory temporal lobe epilepsy. We (1) evaluated long-term DBS in medial temporal lobe structures in patients with normal magnetic resonance imaging (MRI) findings and (2) investigated the use of chronic DBS electrodes for the localization of the ictal onset zone before DBS. In three patients with complex partial seizures (CPSs), DBS electrodes were implanted in the amygdalohippocampal region to identify and subsequently stimulate the ictal onset zone. CPSs were compared before and after chronic DBS. Side effects were carefully monitored. DBS electrodes yielded high-quality electroencephalogram recordings showing unilateral seizure onset in medial temporal lobe structures. For all patients, unilateral amygdalohippocampal stimulation was performed. After a mean follow-up of 5 months (range, 3-6 months), all patients had a greater than 50% reduction in seizure frequency. In two patients, antiepileptic drugs could be tapered. None of the patients reported side effects. This open study demonstrates the feasibility of consecutive electroencephalographic recordings and DBS in medial temporal lobe structures using DBS electrodes. These results prompt further studies in a larger patient population to establish the efficacy and safety of chronic DBS as an alternative treatment for refractory temporal lobe epilepsy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402252     DOI: 10.1002/ana.10323

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  52 in total

1.  Hippocampal deep brain stimulation reduces glucose utilization in the healthy rat brain.

Authors:  Nathalie Van Den Berge; Vincent Keereman; Christian Vanhove; Bregt Van Nieuwenhuyse; Pieter van Mierlo; Robrecht Raedt; Kristl Vonck; Paul Boon; Roel Van Holen
Journal:  Mol Imaging Biol       Date:  2015-06       Impact factor: 3.488

Review 2.  Novel surgical treatments for epilepsy.

Authors:  Guy M McKhann
Journal:  Curr Neurol Neurosci Rep       Date:  2004-07       Impact factor: 5.081

3.  Toward a noninvasive automatic seizure control system in rats with transcranial focal stimulations via tripolar concentric ring electrodes.

Authors:  Oleksandr Makeyev; Xiang Liu; Hiram Luna-Munguía; Gabriela Rogel-Salazar; Samuel Mucio-Ramirez; Yuhong Liu; Yan L Sun; Steven M Kay; Walter G Besio
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2012-07       Impact factor: 3.802

Review 4.  Does interictal synchronization influence ictogenesis?

Authors:  Massimo Avoli; Marco de Curtis; Rüdiger Köhling
Journal:  Neuropharmacology       Date:  2012-07-06       Impact factor: 5.250

5.  Controlling bursting in cortical cultures with closed-loop multi-electrode stimulation.

Authors:  Daniel A Wagenaar; Radhika Madhavan; Jerome Pine; Steve M Potter
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

6.  Brain stimulation for epilepsy: stimulating results?

Authors:  Paul Garcia
Journal:  Epilepsy Curr       Date:  2006 Nov-Dec       Impact factor: 7.500

Review 7.  Deep brain and cortical stimulation for epilepsy.

Authors:  Mathieu Sprengers; Kristl Vonck; Evelien Carrette; Anthony G Marson; Paul Boon
Journal:  Cochrane Database Syst Rev       Date:  2017-07-18

8.  Outcomes remain ambivalent for deep brain stimulation and epilepsy.

Authors:  Elinor Ben-Menachem
Journal:  Epilepsy Curr       Date:  2008 Sep-Oct       Impact factor: 7.500

9.  Frequency dependence of behavioral modulation by hippocampal electrical stimulation.

Authors:  Giorgio La Corte; Yina Wei; Nick Chernyy; Bruce J Gluckman; Steven J Schiff
Journal:  J Neurophysiol       Date:  2013-11-06       Impact factor: 2.714

Review 10.  Deep Brain Stimulation for Epilepsy: Biomarkers for Optimization.

Authors:  Katrina L Dell; Mark J Cook; Matias I Maturana
Journal:  Curr Treat Options Neurol       Date:  2019-09-26       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.